Design of a Multi-Epitope Vaccine using β-barrel Outer Membrane Proteins Identified in Chlamydia trachomatis
Chlamydia trachomatis is an obligate intracellular Gram-negative pathogen responsible for causing sexually transmitted infections (STIs) and trachoma. Current interventions, including screening and antibiotics, are limited due to the widespread nature of asymptomatic infections, and the absence of licensed vaccine exacerbates the challenge. In this study, we predicted outer membrane {beta}-barrel (OMBB) proteins and designed a multi-epitope vaccine (MEV) construct using identified proteins. We employed a consensus-based computational framework on the C. trachomatis D/UW-3/CX proteome and identified 17 OMBB proteins, including well-known Pmp family members and MOMP. Eight OMBB proteins were computationally characterized, which showed significant structural homology with known outer membrane proteins from other bacteria. Sequence-based annotation tools were used to determine their putative functions. B-cell and T-cell epitopes were predicted from the selected proteins. The MEV construct was designed using four cytotoxic T lymphocyte (CTL) epitopes and 29 helper T lymphocyte (HTL) epitopes predicted from six OMBB proteins, which were conserved across 106 C. trachomatis serovars. The vaccine was supplemented at the N-terminus with Cholera enterotoxin subunit B and PADRE sequence to enhance its immunogenicity. The MEV construct of 780 amino acids was antigenic, non-allergenic, non-toxic, and soluble. Secondary structure analysis revealed 95% random coils. The 3D structural model of MEV was generated and validated, confirming its structural reliability. Molecular docking between MEV and Toll-like receptor 4 (TLR4) revealed strong and stable binding interactions, supporting its potential to elicit a strong immune response. This study highlights OMBB proteins as promising immunogenic targets and presents a computationally designed MEV candidate for C. trachomatis infection.